Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorErdoğan, Mümin Alper
dc.contributor.authorTurk, Miray
dc.contributor.authorDoganay, Gizem Dinler
dc.contributor.authorSever, İbrahim Halil
dc.contributor.authorÖzkul, Bahattin
dc.contributor.authorSöğüt, İbrahim
dc.contributor.authorEroğlu, Ebru
dc.contributor.authorUyanikgil, Yigit
dc.contributor.authorErbaş, Oytun
dc.date.accessioned2023-12-16T09:09:45Z
dc.date.available2023-12-16T09:09:45Z
dc.date.issued2023en_US
dc.identifier.citationErdogan, M. A., Turk, M., Doganay, G. D., Sever, I. H., Ozkul, B., Sogut, I., Eroglu, E., Uyanikgil, Y., & Erbas, O. (2023). Prenatal SARS-CoV-2 Spike Protein Exposure Induces Autism-Like Neurobehavioral Changes in Male Neonatal Rats. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 10.1007/s11481-023-10089-4. Advance online publication. https://doi.org/10.1007/s11481-023-10089-4en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12900/250
dc.description.abstractRecent research on placental, embryo, and brain organoids suggests that the COVID-19 virus may potentially affect embryonic organs, including the brain. Given the established link between SARS-CoV-2 spike protein and neuroinflammation, we sought to investigate the effects of exposure to this protein during pregnancy. We divided pregnant rats into three groups: Group 1 received a 1 ml/kg saline solution, Group 2 received 150 mu g/kg adjuvant aluminum hydroxide (AAH), and Group 3 received 40 mu g/kg spike protein + 150 mu g/kg AAH at 10 and 14 days of gestation. On postnatal day 21 (P21), we randomly separated 60 littermates (10 male-female) into control, AAH-exposed, and spike protein-exposed groups. At P50, we conducted behavioral analyses on these mature animals and performed MR spectroscopy. Subsequently, all animals were sacrificed, and their brains were subject to biochemical and histological analysis. Our findings indicate that male rats exposed to the spike protein displayed a higher rate of impaired performance on behavioral studies, including the three-chamber social test, passive avoidance learning analysis, open field test, rotarod test, and novelty-induced cultivation behavior, indicative of autistic symptoms. Exposure to the spike protein (male) induced gliosis and neuronal cell death in the CA1-CA3 regions of the hippocampus and cerebellum. The spike protein-exposed male rats exhibited significantly greater levels of malondialdehyde (MDA), tumor necrosis factor alpha (TNF-alpha), interleukin-17 (IL-17), nuclear factor kappa B (NF-kappa B), and lactate and lower levels of brain-derived neurotrophic factor (BDNF) than the control group. Our study suggests a potential association between prenatal exposure to COVID-19 spike protein and neurodevelopmental problems, such as ASD. These findings highlight the importance of further research into the potential effects of the COVID-19 virus on embryonic and fetal development and the potential long-term consequences for neurodevelopment.en_US
dc.language.isoengen_US
dc.publisherSpringeren_US
dc.relation.isversionof10.1007/s11481-023-10089-4en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCOVID-19en_US
dc.subjectSARS-CoV-2en_US
dc.subjectBaşak proteinien_US
dc.subjectSpike proteinen_US
dc.subjectNörodejenerasyonen_US
dc.subjectNeurodegenerationen_US
dc.subjectNöroinflamasyonen_US
dc.subjectNeuroinflammationen_US
dc.subjectOtizm spektrum bozukluğuen_US
dc.subjectAutism spectrum disorderen_US
dc.subjectBağışıklık sistemien_US
dc.subjectImmune-Systemen_US
dc.subjectCinsiyet Farklılıklarıen_US
dc.subjectSex-Differencesen_US
dc.subjectBeyinen_US
dc.subjectBrainen_US
dc.subjectAktivasyonen_US
dc.subjectActivationen_US
dc.subjectBozukluklaren_US
dc.subjectDisordersen_US
dc.subjectGebeliken_US
dc.subjectPregnancyen_US
dc.subjectÇocuklaren_US
dc.subjectChildrenen_US
dc.subjectPotansiyel müşterileren_US
dc.subjectLeadsen_US
dc.titlePrenatal SARS-CoV-2 Spike Protein Exposure Induces Autism-Like Neurobehavioral Changes in Male Neonatal Ratsen_US
dc.typearticleen_US
dc.departmentİstanbul Atlas Üniversitesi, Meslek Yüksekokulu, Tıbbi Görüntüleme Teknikleri Ana Bilim Dalıen_US
dc.authoridBahattin Özkul/0000-0003-3339-8329en_US
dc.contributor.institutionauthorÖzkul, Bahattin
dc.relation.journalJournal of Neuroimmune Pharmacologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster